Literature DB >> 1892339

Levothyroxine-cholestyramine interaction reemphasized.

S M Harmon, C F Seifert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1892339     DOI： 10.7326/0003-4819-115-8-658_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Concomitant administration of cholestyramine influences the absorption of troglitazone.

Authors:  M A Young; S Lettis; R Eastmond
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

2.  Role of colestipol in the treatment of hyperthyroidism.

Authors:  P Hagag; H Nissenbaum; M Weiss
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

Review 3.  Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature.

Authors:  Mark Messina
Journal:  Nutrients       Date:  2016-11-24       Impact factor: 5.717

Review 4.  Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future.

Authors:  Nattakarn Suwansaksri; Lukana Preechasuk; Tada Kunavisarut
Journal:  Int J Endocrinol       Date:  2018-04-22       Impact factor: 3.257

5.  Pituitary hyperplasia: a complication of the pseudomalabsorption of thyroxine.

Authors:  Mary-Anne Doyle; Heather A Lochnan
Journal:  Int J Gen Med       Date:  2013-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.